Endoplasmic reticulum (ER) stress occurring in stringent conditions is critically involved in cardiomyocytes apoptosis and cardiac contractile dysfunction (CCD). However, the molecular machinery that mediates cardiac ER stress and subsequent cell death remains to be fully deciphered, which will hopefully provide novel therapeutic targets for these disorders. Here, we establish tunicamycin-induced model of cardiomyocyte ER stress, which effectively mimicks pathological stimuli to trigger CCD. Tunicamycin activates volume-sensitive outward rectifying Cl − currents. Blockade of the volume-sensitive outwardly rectifying (VSOR) Cl − channel by 4,4'-diisothiocya-natostilbene-2,2'-disulfonic acid (DIDS), a non-selective Cl − channel blocker, and 4-(2-butyl-6,7-dichlor-2-cyclopentyl-indan-1-on-5-yl) oxybutyric acid (DCPIB), a selective VSOR Cl − channel blocker, improves cardiac contractility, which correlates with suppressed ER stress through inhibiting the canonical GRP78/eIF2α/ATF4 and XBP1 pathways, and promotes survival of cardiomyocytes by inverting tunicamycin-induced decrease of Wnt through the CHOP pathway. VSOR activation of tunicamycin-treated cardiomyocytes is attributed to increased intracellular levels of reactive oxygen species (ROS). Our study demonstrates a pivotal role of ROS/VSOR in mediating ER stress and functional impairment of cardiomyocytes via the CHOP-Wnt pathway, and suggests the therapeutic values of VSOR Cl − channel blockers against ER stress-associated cardiac anomalies.
Endoplasmic reticulum (ER) stress occurring in stringent conditions is critically involved in cardiomyocytes apoptosis and cardiac contractile dysfunction (CCD). However, the molecular machinery that mediates cardiac ER stress and subsequent cell death remains to be fully deciphered, which will hopefully provide novel therapeutic targets for these disorders. Here, we establish tunicamycin-induced model of cardiomyocyte ER stress, which effectively mimicks pathological stimuli to trigger CCD. Tunicamycin activates volume-sensitive outward rectifying Cl − currents. Blockade of the volume-sensitive outwardly rectifying (VSOR) Cl − channel by 4,4'-diisothiocya-natostilbene-2,2'-disulfonic acid (DIDS), a non-selective Cl − channel blocker, and 4-(2-butyl-6,7-dichlor-2-cyclopentyl-indan-1-on-5-yl) oxybutyric acid (DCPIB), a selective VSOR Cl − channel blocker, improves cardiac contractility, which correlates with suppressed ER stress through inhibiting the canonical GRP78/eIF2α/ATF4 and XBP1 pathways, and promotes survival of cardiomyocytes by inverting tunicamycin-induced decrease of Wnt through the CHOP pathway. VSOR activation of tunicamycin-treated cardiomyocytes is attributed to increased intracellular levels of reactive oxygen species (ROS). Our study demonstrates a pivotal role of ROS/VSOR in mediating ER stress and functional impairment of cardiomyocytes via the CHOP-Wnt pathway, and suggests the therapeutic values of VSOR Cl − channel blockers against ER stress-associated cardiac anomalies. The endoplasmic reticulum (ER) is characterized as an organelle that participates in the folding of membrane and secretory proteins. 1, 2 Efficient functioning of the endoplasmic reticulum is important for cell function and survival. Perturbations of ER homeostasis by energy deprivation and glucose, 3 viral infections 4 and accumulation of misfolded and/or unfolded proteins 2 interfere with ER function, leading to a state of ER stress. [5] [6] [7] A cohort of chemicals, for example, tunicamycin and thapsigargin, also trigger ER stress. [8] [9] [10] Thapsigargin disrupts the calcium storage of ER by blocking calcium reuptake into the ER lumen, thus by depleting calcium from the organelle. 11 In particular, tunicamycin is a highly specific ER stress inducer by inhibiting N-linked glycosylation of protein, representing a well-documented method to artificially elicit unfolded protein response. 8 In response to ER stress, ER chaperones such as glucose-regulated protein 78 kDa (GRP78) and glucose-regulated protein 94 kDa (GRP94) are upregulated to facilitate the recovery of unfolded or misfolded proteins. 12 ER stress may act as a defense mechanism against external insults; however, prolonged and/ or severe ER stress may ultimately trigger apoptosis. 8 The C/EBP homologous protein (CHOP) has been defined as a pivotal mediator of cell death signaling in ER stress. 13, 14 Accumulating evidence has demonstrated that ER stressinduced cell death is an essential step in the pathogenesis of a wide variety of cardiovascular diseases such as ischemia reperfusion heart diseases, 15 atherosclerosis, 5,16-18 myocardial infarction, 19 hypertension 20, 21 and heart failure. 8, 22, 23 Inhibiting ER stress has great therapeutic values for cardiac anomalies. However, the precise mechanism involved in ER stress-induced cardiovascular diseases has not been well identified, which impedes the translation of our understanding of ER stress-induced cardiovascular anomalies into effective therapeutic strategies. Apoptosis induction requires persistent cell shrinkage, named apoptotic volume decrease (AVD). [24] [25] [26] [27] It is an early prerequisite for the activation of caspases. 24 In various types of cells including cardiomyocytes, AVD process is accomplished by the activation of volume-sensitive outwardly rectifying (VSOR) Cl − channel and is concomitant with the egress of water from the cells undergoing mitochondrioninitiated or death receptor-induced apoptosis. 25, [28] [29] [30] (4,4'-diisothiocyanatostilbene-2,2'-disulphonic acid) and DCPIB (4-(2-butyl-6,7-dichlor-2-cyclopentyl-indan-1-on-5-yl) oxybutyric acid) blocked AVD and rescued cardiomyocytes from mitochondrial and death receptor pathway-induced apoptosis, 31, 32 it remains largely unknown concerning the role of VSOR Cl − channel and how it is regulated in ER stressinduced apoptotic cardiomyocyte death.
Emerging evidence indicates that Wnt signal pathways are found to be anti-apoptotic in the cardiovascular diseases, [33] [34] [35] regulating crucial aspects of cardiovascular biology. However, up to now, its activity in ER stress-induced apoptosis and in the process of AVD in cardiomyocytes remains elusive.
In the present study, we probed the role of VSOR Cl − channel in ER stress-induced apoptosis of cardiomyocytes, which intimately correlates with cardiac contractile dysfunction (CCD). We hypothesized that VSOR Cl − channel controls the process of AVD occurring concomitantly with ER stressinduced apoptosis of cardiomyocytes. To test this hypothesis, we investigated VSOR Cl − currents in cardiomyocytes treated with the ER stress inducer tunicamycin. The pathophysiological role of VSOR Cl − channel and the potential signaling mechanisms in the development of ER stress-induced apoptosis in CCD were also dissected.
Results
ER stress inducer tunicamycin rapidly activates volumesensitive chloride currents in cardiomyocytes. Volumesensitive chloride channel is critically involved in apoptotic volume decrease (AVD) and cell death of the cardiovascular diseases. Tunicamycin has been commonly employed as a classical pro-apoptotic inducer through the ER stress pathway. 10 To explore whether volume-sensitive chloride channel also participates in ER stress-induced apoptosis, we examined the effect of ER stress inducer tunicamycin on VSOR Cl − currents in cardiomyocytes. The cellular electrophysiological studies were performed to directly monitor the VSOR Cl − currents. Cardiomyocytes were stimulated with tunicamycin (3 μg/ml, 10-15 min), and the properties of whole cell currents were recorded. Compared with the currents recorded under control conditions, tunicamycin challenges rapidly increased the conductance, which was likely to be I cell,swell : voltage-dependent inactivation at large positive voltages ( Figure 1a ) and outward rectification (Figure 1b) , Furthermore, the tunicamycin-induced currents were markedly inhibited by VSOR blockers DIDS (Figures 1a, 500 μM, 5-6 min, 82.05 ± 4.37%, n = 5, Po0.05) and DCPIB ( Figures  1d, 10 μM, 6-7 min, 91.33 ± 5.57%, n = 5, Po0.05). The properties of tunicamycin-induced current changes indicate that tunicamycin activates VSOR Cl − currents in cardiomyocytes.
VSOR Cl
− channel blockers rescue ER stress and cell injury in tunicamycin-exposed cardiomyocytes. From the above data, we can see that VSOR Cl − currents from the tunicamycin group activate more than that of the control. However, molecular identity of VSOR Cl − channel remains unknown. To test whether VSOR Cl − channel mediates tunicamycin-induced ER stress of cardiomyocytes, we treated cells with DIDS, a non-selective Cl − channel blocker, and DCPIB, a selective VSOR Cl − channel blocker. Our study and others proved that ER stress-related proteins such as GRP78, p-eIF2α and ATF4 reached their peak after 100 ng/ml tunicamycin exposure for 24 h (data not shown). DIDS and DCPIB application significantly suppressed tunicamycin-induced upregulation of chaperone protein GRP78 and the transcriptional factor ATF4 (Figures 2a and  c) , and downregulation of XBP1S (Figure 2b ). DIDS and DCPIB also attenuated the phosphorylation of eIF2α occurring in tunicamycin-triggered ER stress (Figure 2c ). Furthermore, DIDS and DCPIB not only decreased the cellular level of the C/EBP homologous protein (CHOP), but also inhibited the nuclear translocation of CHOP (Figures 2c and d) . Therefore, suppression of VSOR Cl − channel by DIDS and DCPIB impedes tunicamycin-induced ER stress of cardiomyocytes.
We next probed the role of VSOR Cl − channel in ER stressinduced apoptosis of cardiomyocytes. DIDS and DCPIB treatment protected cardiomyocytes from tunicamycininduced impairment of cell viability (Figure 3a) . Consistently, tunicamycin-elicited apoptosis of cardiomyocytes was inhibited by DIDS and DCPIB, as revealed by TUNEL staining and activation detection of capase-3 (Figures 3b and c) .
− channel blockers protect cardiomyocytes through the CHOP-Wnt pathway. To explore the involvement of Wnt on tunicamycin-induced cardiomyocyte injury, β-catenin was examined in cardiomyocytes. Our data showed that tunicamycin significantly decreased the nuclear localization of β-catenin (Figure 4a ). In addition, tunicamycin could also decrease Topflash activity (Figure 4c ). Moreover, Topflash activity reversely correlated with CHOP ( Figure 4b ). Interestingly, siCHOP prevented the downregulation of Topflash activity induced by tunicamycin (Figures 4c  and d) , suggesting that Wnt is a CHOP target in vitro.
Treatment with DIDS and DCPIB markedly increased Topflash activity compared with the tunicamycin group (Figure 4c ), whereas siCHOP and DIDS, DCPIB combination had no extra effect on Topflash activity, compared with siCHOP alone (Figure 4d ). Taken together, VSOR Cl − channel blockers invert tunicamycin-induced Wnt expression through CHOP-dependent regulation.
Next, we examined the cell viability. siCHOP or treatment with DIDS and DCPIB improved the cell survival (Figure 4g ), whereas siCHOP and VSOR Cl − channel blockers DIDS and DCPIB together had no extra effect on cell viability induced by tunicamycin. Taken together, VSOR Cl − channel blockers protect cardiomyocytes from tunicamycininduced apoptosis through CHOP. To investigate the role of Wnt in VSOR Cl − channel blockers-induced protective effect, sFRP was used to inhibit Wnt. sFRP itself had no obvious effect on cell apoptosis (data not shown). In contrast, the Wnt activition by DIDS and DCPIB was nearly fully reversed by sFRP (Figure 4e ), and the anti-apoptotic effect of DIDS and DCPIB was nearly fully blunted by sFRP (Figure 4h ). Taken together, VSOR Cl − channel blockers protect cardiomyocytes from tunicamycin-induced apoptosis through regulation of Wnt.
To determine the functional significance of the CHOP-Wnt pathway, siCHOP and sFRP were used to inhibit CHOP and Wnt, respectively. The Wnt activition effect of siCHOP and/or VSOR Cl − channel blockers was nearly fully reversed by sFRP (Figure 4f ), and the anti-apoptotic effect of siCHOP and/or VSOR Cl − channel blockers was nearly inhibited by sFRP ( Figure 4i ). Taken together, these results support the concept that VSOR Cl − channel blockers protect cardiomyocytes from tunicamycin-induced apoptosis through CHOP-dependent regulation of Wnt expression. ). Thus, apparent ROS production occurs concomitantly with tunicamycin-induced ER stress. Next, we explored whether ROS mediate VSOR Cl − currents in tunicamycin-exposed cardiomyocytes. Hydrogen peroxide (H 2 O 2 ) and ROS scavenger NAC were used to mimic ROS and block ROS production in cardiomyocytes, respectively. Extracellular application of H 2 O 2 (500 μM, 7-10 min) directly elicited VSOR Cl − currents, which could be inhibited by DIDS (500 μM, 5-7 min, 77.49 ± 3.11%, n = 5, Po0.05) and DCPIB (10 μM, 6-7 min, 88.74 ± 4.86%, n = 5, Po0.05) ( Figure 6 ). In addition, tunicamycin-induced activation of VSOR Cl − currents was almost completely abolished through scavenging ROS with NAC (10 mM, 5-10 min, 99.07 ± 5.86%; n = 5, Po0.05) (Figure 7) . Therefore, ROS production is pivotally involved in VSOR Cl − channel activation.
Increased ROS mediate VSOR Cl

VSOR Cl
− channel blockers in vivo counteract ER stresstriggered cardiomyocyte apoptosis and improve cardiac function. To evaluate the effects of ER stress on cardiac contractile function in vivo, mice were administered with tunicamycin (3 mg/kg, i.p. for 48 h), and left ventricular eject fraction (LVEF) was measured by echocardiography. Tunicamycin challenge did not significantly affect the body or organ (the lung, liver or kidney) weight, or the heart size (heart-tobody weight ratio) and the heart rate. In addition, LV wall thickness and ventricular septal thickness were comparable among all groups (Data not shown). In contrast, tunicamycin challenges significantly increased p-eIF2α, ATF4 and CHOP, and decreased XBP1S, LVEF, suggesting that tunicamycin led to ER stress-induced cardiac contractile dysfunction (Figures 8 and 9a ). Given that ER stress is known to elicit myocardial damage through apoptotic cell death, we next examined the effect of tunicamycin on apoptosis of cardiomyocytes. TUNEL assay revealed that tunicamycin induced apparent apoptosis (Figure 9b ). Therefore, tunicamycin triggers serious apoptosis of cardiomyocytes, providing an To investigate whether blocking VSOR Cl − channel could improve ER stress-triggered cardiac contractile dysfunction, DIDS and DCPIB were used to block VSOR Cl − channel in tunicamycin-administered mice, respectively. As a result, DIDS and DCPIB treatment significantly increased XBP1S and decreased p-eIF2α, ATF4, CHOP, TUNEL-stained cell numbers, suggesting an inhibition of tunicamycin-induced apoptosis of cardiomyocytes by VSOR Cl − channel blockers (Figures 8 and 9b ). Echocardiography showed that DIDS and DCPIB mitigated the cardiac function impairment caused by tunicamycin, respectively (Figure 9a ). Therefore, blockade of VSOR Cl − channel protects cardiomyocytes from ER stress-induced apoptosis or loss of contractility.
Discussion
CCD represents the common clinical manifestation of a class of cardiovascular disorders. Given that the etiologic conditions of CCD, for example, atherosclerosis, ischemia/reperfusion injury of the heart, alcoholic cardiomyopathy, autoimmune cardiomyopathy, myocardial infarction, cardiac hypertrophy and heart failure frequently dampen protein folding or cause calcium depletion in the ER, 36-39 the essential role of ER stress in CCD has began to be unveiled. Consistent with accumulating studies demonstrating the critical involvement of ER stress under various cardiac pathological states, 16, 36, 40 we found that tunicamycin-induced ER stress promoted apoptosis and severely impaired the cardiac contractility. ER stress inducer tunicamycin caused excessive generation of ROS, which consequently activated VSOR Cl − channel and ultimately accelerated ER stress, and thus apoptosis of cardiomyocytes by inhibition of Wnt activation (Figure 9c) . The newly unraveled ROS-and VSOR-dependent pathways are critically involved in ER stress-related cardiac contractile dysfunction in a mouse CCD model.
Despite the defined roles of ER stress-related apoptosis of cardiomyocytes in cardiovascular diseases such as myocardial infarction, ischemia-reperfusion injury, cardiomyopathy, atherosclerosis and heart failure, it remains largely uncharacterized how these abnormalities activate the molecular machineries of ER stress and related apoptosis of cardiac myocytes. However, accumulating data have suggested the production of ROS under the aforementioned pathological conditions. [41] [42] [43] Given the established role of ROS in inducing ER stress, we propose that in addition to triggering ER stress via disruption of protein N-glycosylation and proper folding, tunicamycin also propagates ER stress by facilitating excessive ROS generation, which is supported by both our findings and previous reports that tunicamycin treatment resulted in a profound increase in intracellular ROS. 44, 45 ROS have been well-documented in mediating cell signals leading to organelle damage, tissue and organ degeneration, and aging. 46 The production of ROS was found to correlate closely with myocardial infarction, ischemia-reperfusion injury, cardiomyopathy, atherosclerosis and heart failure. 47, 48 ROS is also involved in other cellular processes, for example, the activation of ion channels. 49 Presumably due to the multifaceted roles of ROS in stress signaling, we established that tunicamycin treatment of cardiomyocytes leads to extensive activation of the canonical signaling of the ER stress, mainly the eIF2α/ ATF4 and XBP1S pathways. Therefore, tunicamycin-elicited ER stress may appropriately mimick the complicated environmental stimuli responsible for the development of cardiovascular diseases.
Apoptosis induction requires persistent cell shrinkage, that is, AVD, reminiscent of the role of VSOR Cl − channel in the outward rectifying Cl − currents in cardiomyocytes. 24 Blockade of chloride channel by DIDS and DCPIB could prevent cardiomyocyte apoptosis. 31, 50 The volume-sensitive chloride channel inhibitors IAA-94 and DIDS prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3K, Akt and Erk 1/2. 51 Although VSOR Cl − channel participated in apoptosis via the mitochondrial or death receptor pathway, whether VSOR Cl − channel-induced AVD participates in ER stress is still unknown. Our data revealed that tunicamycin increased the densities of VSOR Cl − currents, which displayed voltage-dependent inactivation at large positive voltages. The tunicamycin-induced activation of VSOR Cl − channel was inhibited by adding DIDS, a non-selective Cl − channel blocker. To distinguish from other possible styles of Cl − currents, DCPIB, a selective inhibitor of VSOR Cl − channel, was selected and our data revealed that DCPIB effectively inhibits tunicamycininduced VSOR Cl − currents. DIDS and DCPIB decreased ER stress signaling and reduced apoptosis of cardiomyocytes and mitigated CCD in animals, respectively. Albeit principally activated by osmotic cell swelling, [52] [53] [54] VSOR Cl − channel has recently been found activated by ROS eliciting cell swelling. 29, [55] [56] [57] [58] In agreement with these reports, we established here that extracellular application of H 2 O 2 activated VSOR Cl − currents, which was blocked by DIDS and DCPIB, respectively. Moreover, tunicamycin-induced activation of VSOR Cl − currents was almost completely eliminated by the antioxidant NAC. These data indicate that ROS are required for tunicamycin-induced VSOR activation. However, further investigations are necessary to dissect the molecular link between VSOR activation and ER stress. Given the characterized role of calcium channel in mediating cell responses to osmotic changes, 59 it is worth further investigation whether VSOR elicits ER stress via cell volume regulation and subsequently disruption of Ca 2+ homeostasis. Next, we demonstrated that DIDS and DCPIB significantly decrease tunicamycin-induced CHOP upregulation, respectively. These results suggest that DIDS and DCPIB attenuate tunicamycin-induced ER stress through the CHOP pathway. However, the precise downstream of CHOP remains to be further elucidated.
Wnt is an essential cell protective mediator under multiple conditions. Wnt is an important effector in the anti-apoptotic signaling. Previous study revealed that increased Wnt signal by dishevelled-1 knockdown attenuates cyclosporine A-induced apoptosis in H9C2 cardiomyoblast cells. 33 However, whether Wnt participates in ER stress-induced cardiomyocyte apoptosis has not been reported. In our study, tunicamycin downregulated Wnt activity, while siCHOP inverted downregulation of Wnt induced by tunicamycin. These indicate that Wnt is a CHOP-regulated gene in Autophagy is an essential survival mechanism during energy stress in the heart. 60 Moreover, autophagy has cytoprotective role during ER stress and can delay or prevent UPR-dependent apoptosis activation to relieve the stress. 11 Next, we will try to elucidate the relationship of VSOR chloride channel, autophagy and ER stress. Our study provides strong evidence that tunicamycin results in excessive generation of ROS in the heart, which in turn activates VSOR Cl − currents. Increased VSOR Cl − currents lead to ER stress, resulting in increased cell apoptosis and cardiac contractile dysfunction through CHOP-dependent regulation of Wnt expression, demonstrating the feasibility for future treatment of CCDs with VSOR Cl − channel blockers. Tunicamycin results in increased ROS production in the heart, which in turn activates VSOR Cl − currents. VSOR Cl − currents lead to increased ER stress, resulting in increased cell apoptosis and cardiac contractile dysfunction through CHOP-dependent regulation of Wnt expression. 10 Control mice were given similar amount of saline (i.p.). Animals were killed by intraperitoneal injection of ketamine (200 mg/kg) and xylazine (100 mg/kg), and hearts were rapidly excised. Then, the hearts were harvested, and frozen sections were prepared. TUNEL staining was performed using the in situ TUNEL cell death detection kit (Roche Applied Science), followed by nuclear counterstaining with DAPI.
Primary culture of cardiomyocytes and induction of ER stress in vitro. Cardiomyocytes were prepared from newborn Sprague-Dawley rats as described previously. 30 Neonatal rats were killed by decapitation. In brief, neonatal rat ventricles were enzymatically digested, and cardiomyocytes were purified through 1 h incubation. Cardiomyocytes were cultured in DMEM medium supplemented with 10% fetal bovine serum and 100 μM BrdU for 16-24 h. To elicit ER stress in vitro, isolated cardiomyocytes were incubated with tunicamycin (100 ng/ml) at 37°C.
Echocardiography to assess cardiac function. Cardiac function was measured using echocardiography (VisualSonics VeVo 770) 48 h after tunicamycin (3 mg/kg) i.p. injection. Mice were anesthetized with isoflurane (2.5%, 10 μl/g). Determination of cell viability. Cell viability was assessed by MTT assay. In brief, cardiomyocytes were plated into 96-well culture plates at a density of 5 × 10 4 /well (100 μl). MTT was added into each well with a final concentration of 0.5 mg/ml, and cells were incubated for 4 h at 37°C. The formazan crystals were dissolved in dimethyl sulfoxide (DMSO, 150 μl/well). The absorbance was detected at 490 nm using a microplate reader (Bio-Rad, Philadelphia, PA, USA).
Tunel assay. Apoptosis was assayed by TUNEL staining using the in situ TUNEL cell death detection kit according to the manufacturer's instructions. In brief, cells were fixed with 4% paraformaldehyde and permeabilized with 0.3% Triton X-100 for 1 h at room temperature, and then washed twice with PBS. Cells were then incubated with the TUNEL assay reaction mixture at 37°C for 1 h, followed by nuclear counterstaining with DAPI. The number of TUNEL-positive cells in each field was counted and expressed as a percentage of the total number of cells.
Patch-clamp experiments. The VSOR Cl − currents were recorded with an Axon Multiclamp 700B amplifier and Digidata1322A (Axon Instruments, Foster, CA, USA) using the whole-cell configuration. Voltage clamp protocols ( Figure 10 ) and data acquisition were controlled by pClamp10 software. Pipettes were fabricated from borosilicate glass capillaries using a micropipette puller (P-2000, Sutter Instrument, Novato, CA, USA) with resistance of 3-5 MΩ when filled with pipette solution. Liquid junction potentials were calculated with JPCalc in pClamp 10 and corrected on-line. For whole-cell recordings, the capacitative transients and access resistance were maximally compensated. The pipette solution (103 mM CsOH, 103 mM Aspartic acid, 25 mM CsCl, 5 mM Mg-ATP, 0.3 mM Na 3 -GTP, 5 mM EGTA, 10 mM HEPES, and 30 mM mannitol, pH7. 4 channel, respectively. The osmolality of all solutions was measured using a freezing-point depression osmometer (OM802, Vogel, Giessen, Germany).
Immunofluorescence for expression of GRP78 and CHOP in cardiomyocytes. Cardiomyocytes were incubated with indicated doses of drugs. Next, cells were fixed with 4% paraformaldehyde for 10 min and permeabilized with 0.3% Triton X-100 for 1 h at room temperature. Immunofluorescence assessment of cardiomyocyte expression of GRP78 was carried out using cardiomyocyte-specific mouse monoclonal anti-α-actinin (1 : 100 in antibody dilution) and rabbit polyclonal anti-GRP78 (1 : 100 in antibody dilution), followed by staining with goat anti-mouse secondary Flour-594 antibody (1 : 200 in antibody dilution; Invitrogen, Carlsbad, CA, USA) and goat anti-rabbit secondary Alexa Flour 488 (1 : 200 in antibody dilution; Invitrogen). Cardiomyocyte expression of CHOP was carried out using mouse monoclonal anti-α-actinin (1 : 100 in antibody dilution) and rabbit polyclonal anti-CHOP (1 : 100 in antibody dilution), followed by staining with goat anti-mouse secondary Flour-594 antibody (1 : 200 in antibody dilution; Invitrogen) and goat anti-rabbit secondary Alexa Flour 488 (1 : 200 in antibody dilution; Invitrogen). The sections were observed and images were captured by confocal laser scanning microscopy (Nikon, Tokyo, Japan).
H9C2 cell culture and RNA interference. H9C2 cells, a cell line derived from fetal rat heart, were purchased from American Type Culture Collection (ATCC, USA) for the siRNA and repoter assay study due to the poor transfection efficacy of primary cultured rat cardiomyocytes. Cells were cultured in DMEM medium containing 10% fetal bovine serum (FBS) in a 5% CO 2 incubator at 37°C.
Small interfering RNA against CHOP was performed as described previously. 61 CHOP-specific short interfering RNA (siCHOP) was obtained from GenePharma (Shanghai, China). Target sequence of siCHOP was 5′-CGAAGAGGAAGAAUCAA-A-3′, and the negative control sequence was 5′-UUCUCCGAACGUGUCACGU-TT-3′.
Reporter assay. Topflash and internal control pRL-TK vectors were co-transfected into H9C2 cells. After transfection for 36 h, H9C2 cells were lysed using passive lysis buffer. Firefly and Renilla luciferase activities were analyzed using the dual-luciferase reagent assay kit (Promega, USA) according to the manufacturer's instructions.
Western blot analysis. Cardiomyocytes were lysed by RIPA containing a protease inhibitor cocktail. Electrophoresis and immunobloting were done as described previously. 62 For the densitometric analysis, optical density was measured on the inverted digital images using Image J software.
Quantitative real-time PCR. cDNA synthesis was performed with QuantiTect Reverse Transcription Kit (TaKaRa Biotech, Dalian, China). PCR was performed on an ABI prism 7500 with the Power SYBR Green PCR Master Mix (TaKaRa Biotech, China). β-actin was used as an endogenous control to normalize the amount of RNA. XBP1S forward: 5'-GCTTGTGATTGAGAACCAGG-3' and reverse:
5'-GGCCT Figure 10 Corresponding step protocol used to elicit current trace. To observe the current-voltage relationships, step pulses were generated from a holding potential of −40 mV to test potentials from − 100 to +100 mV with 20 mV increments. To record the greater magnitude of pulse-induced currents, the − 100 mv conditioning pulse was applied before and after test potentials.
GCACCTGCTGCGGACTC-3'; β-actin forward: 5'-AGAGGGAAATCGTGCGTGAC-3' and reverse: 5'-TTCTCCAGGGAGGAAGAGGAT-3'.
Intracellular fluorescence measurement of O 2
−
. Intracellular superoxide was monitored by changes in fluorescence intensity resulting from intracellular probe oxidation according to the previously described method. 63 Cardiomyocytes were loaded with 5 μM dihydroethidium (DHE) for 30 min at 37°C and washed twice with PBS buffer. Cells were captured using a confocal microscope (Nikon).
Statistical analysis. Results were presented as mean ± S.E.M. All data were subjected to ANOVA, followed by Bonferroni correction for post-test. Po0.05 was considered statistically significant.
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